Overview
This page compares HTX and Injective with live PEPS metrics. Rankings (#47 vs #99) and liquidity profiles differ, so traders often use them for distinct roles rather than as perfect substitutes.
Quick winners
Full comparison
| Metric | HTX | INJ |
|---|---|---|
| Price | $1,867.53 | $5.00 |
| Market Cap | $1.61B | $490.41M |
| FDV | — | — |
| Volume 24h | $64.41M | $2.50M |
| Circulating Supply | — | — |
| Total Supply | — | — |
| Max Supply | — | — |
| Rank | 47.00 | 99.00 |
| Dominance | — | — |
| Liquidity | — | — |
| Volatility | +3.64% | +5.97% |
| ATH | — | — |
| ATL | — | — |
| ROI | — | — |
Performance
| Timeframe | HTX | INJ |
|---|---|---|
| 1H | — | — |
| 24H | +0.00% | +1.77% |
| 7D | — | — |
| 30D | — | — |
| 90D | — | — |
| 1Y | — | — |
| YTD | — | — |
| ALL | — | — |
Comparative chart
Technical indicators
| Indicator | HTX | INJ |
|---|---|---|
| RSI | 49.02 | 49.29 |
| MACD histogram | — | — |
| EMA20 | — | — |
| EMA50 | — | — |
| EMA100 | — | — |
| EMA200 | — | — |
| SMA50 | — | — |
| SMA200 | — | — |
| ATR | 67.35 | 0.29 |
| ADX | 21.33 | 12.19 |
| Support | 1,827.82 | 4.91 |
| Resistance | 1,960.30 | 5.07 |
| Trend | bearish | neutral |
| Momentum | 65.00 | — |
| Signal | neutral | neutral |
Automatic technical analysis
When RSI and trend disagree across HTX and Injective, expect choppy relative performance until one side reclaims a clear structure.
Fundamentals
| Metric | HTX | INJ |
|---|---|---|
| Consensus | — | — |
| Blockchain | — | — |
| TPS | — | — |
| Block time | — | — |
| Finality | — | — |
| Validators | — | — |
| Staking | — | — |
| TVL | — | — |
| Supply model | — | — |
| Inflation | — | — |
| Developer activity | — | 0.00 |
| Github activity | — | 118.00 |
| On-chain activity | — | — |
| Whale activity | — | — |
| Addresses | — | — |
| Gas fees | — | — |
Ecosystem
HTX
Injective
Pros and cons
Pros of HTX
- Market-cap scale on HTX may dampen some idiosyncratic shocks versus smaller peers.
- HTX typically benefits from deeper liquidity and broader market recognition inside the Top 300 set.
- HTX has an established coin page footprint on PEPS for continuous monitoring.
- HTX often anchors narratives that attract sustained media and analyst coverage.
Cons of HTX
- Data gaps in niche fundamentals still apply — absence of a field is not confirmation.
- When dominance narratives fade, HTX can lag hotter rotation names.
- Indicator stacks on HTX may stay stretched longer than expected in strong trends.
Pros of Injective
- Injective can offer higher relative beta when market attention rotates toward its niche.
- PEPS tracking for Injective still includes AI score and level context for monitoring.
- Narrative optionality around Injective can reprice quickly when catalysts appear.
- If technical momentum aligns, Injective may outperform on medium-term windows.
Cons of Injective
- Incomplete fundamental coverage can hide operational or tokenomic risks.
- Relative underperformance versus HTX can persist through entire market regimes.
- Weaker market-cap standing may leave Injective more exposed to liquidity droughts.
- Higher volatility on INJ cuts both ways and demands stricter risk limits.
Which looks stronger right now?
The “stronger” label here is descriptive, not predictive. HTX and Injective can alternate leadership as macro liquidity and narrative rotate.
AI summary
Comparing HTX and INJ begins with structure: capitalization, volume and rank. Present prints are $1,867.53 versus $5.00. Momentum and trend can disagree with market-cap hierarchy. That is normal in crypto rotations and should be stress-tested against supports and news flow. Canonical URLs prevent duplicate INJ-vs-HTX pages, keeping SEO equity on one comparison. Keep monitoring winners as data updates.
FAQ
Which is better, HTX or Injective?
“Better” depends on horizon and risk. HTX leads on market cap today, while Injective leads the 24h move — neither is a guarantee.
Which has more upside potential, HTX or INJ?
Higher-beta assets can move more in both directions. Use performance tables and volatility, not headlines, to judge potential ranges.
Which is less risky right now?
Lower volatility and deeper liquidity usually imply milder path risk, but crypto tails remain large for both HTX and Injective.
Which has stronger developer activity?
Check the fundamentals table for developer/github fields when populated. Missing values mean the feed has no reliable reading yet.
Which looks more decentralized?
Decentralization is multi-dimensional (validators, client diversity, token distribution). This page surfaces available consensus/validator fields without over-claiming.
Which has lower fees?
Fee comparisons belong to each network’s fee market. Where gas/fee metrics exist in fundamentals, compare them; otherwise verify on explorers.
Which is better for investing?
Investing choices need personal constraints. Use this comparison as research input, then size positions with an explicit invalidation plan.
Which is better for staking?
If staking fields are present, compare yield mechanics and lockups off-platform. Staking returns are not risk-free.
Which is more used day to day?
Volume, on-chain activity and ecosystem links are practical usage proxies. HTX currently leads traded volume on this snapshot.
Which has the better recent performance?
See the performance table across 1h through 1y. The 24h leader is Injective, but longer windows can disagree.